189 related articles for article (PubMed ID: 1383226)
1. Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex.
Wiederrecht G; Hung S; Chan HK; Marcy A; Martin M; Calaycay J; Boulton D; Sigal N; Kincaid RL; Siekierka JJ
J Biol Chem; 1992 Oct; 267(30):21753-60. PubMed ID: 1383226
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of calcineurin by a novel FK-506-binding protein.
Sewell TJ; Lam E; Martin MM; Leszyk J; Weidner J; Calaycay J; Griffin P; Williams H; Hung S; Cryan J
J Biol Chem; 1994 Aug; 269(33):21094-102. PubMed ID: 7520438
[TBL] [Abstract][Full Text] [Related]
3. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.
Baughman G; Wiederrecht GJ; Campbell NF; Martin MM; Bourgeois S
Mol Cell Biol; 1995 Aug; 15(8):4395-402. PubMed ID: 7542743
[TBL] [Abstract][Full Text] [Related]
4. Regulation of calcineurin phosphatase activity and interaction with the FK-506.FK-506 binding protein complex.
Parsons JN; Wiederrecht GJ; Salowe S; Burbaum JJ; Rokosz LL; Kincaid RL; O'Keefe SJ
J Biol Chem; 1994 Jul; 269(30):19610-6. PubMed ID: 7518461
[TBL] [Abstract][Full Text] [Related]
5. A novel FK506 binding protein can mediate the immunosuppressive effects of FK506 and is associated with the cardiac ryanodine receptor.
Lam E; Martin MM; Timerman AP; Sabers C; Fleischer S; Lukas T; Abraham RT; O'Keefe SJ; O'Neill EA; Wiederrecht GJ
J Biol Chem; 1995 Nov; 270(44):26511-22. PubMed ID: 7592869
[TBL] [Abstract][Full Text] [Related]
6. Immunophilins interact with calcineurin in the absence of exogenous immunosuppressive ligands.
Cardenas ME; Hemenway C; Muir RS; Ye R; Fiorentino D; Heitman J
EMBO J; 1994 Dec; 13(24):5944-57. PubMed ID: 7529175
[TBL] [Abstract][Full Text] [Related]
7. FK-506 binding protein from Tolypocladium inflatum: resistance of FKBP/FK-506 complex against proteolysis.
Lee C; Hoffmann K; Zocher R
Biochem Biophys Res Commun; 1992 Feb; 182(3):1282-7. PubMed ID: 1371677
[TBL] [Abstract][Full Text] [Related]
8. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
[TBL] [Abstract][Full Text] [Related]
9. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
Bell A; Wernli B; Franklin RM
Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
[TBL] [Abstract][Full Text] [Related]
10. FK506 binding protein mutational analysis. Defining the surface residue contributions to stability of the calcineurin co-complex.
Futer O; DeCenzo MT; Aldape RA; Livingston DJ
J Biol Chem; 1995 Aug; 270(32):18935-40. PubMed ID: 7642551
[TBL] [Abstract][Full Text] [Related]
11. Expression and characterization of human FKBP52, an immunophilin that associates with the 90-kDa heat shock protein and is a component of steroid receptor complexes.
Peattie DA; Harding MW; Fleming MA; DeCenzo MT; Lippke JA; Livingston DJ; Benasutti M
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10974-8. PubMed ID: 1279700
[TBL] [Abstract][Full Text] [Related]
12. Immunophilin-sensitive protein phosphatase action in cell signaling pathways.
Schreiber SL
Cell; 1992 Aug; 70(3):365-8. PubMed ID: 1379518
[No Abstract] [Full Text] [Related]
13. The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells.
Fruman DA; Bierer BE; Benes JE; Burakoff SJ; Austen KF; Katz HR
J Immunol; 1995 Feb; 154(4):1846-51. PubMed ID: 7530743
[TBL] [Abstract][Full Text] [Related]
14. NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs.
McCaffrey PG; Perrino BA; Soderling TR; Rao A
J Biol Chem; 1993 Feb; 268(5):3747-52. PubMed ID: 7679116
[TBL] [Abstract][Full Text] [Related]
15. Schistosoma mansoni: characterization of p50, an immunophilin.
Osman A; Kiang D; Lo Verde PT; Karim AM
Exp Parasitol; 1995 May; 80(3):550-9. PubMed ID: 7537219
[TBL] [Abstract][Full Text] [Related]
16. Charged surface residues of FKBP12 participate in formation of the FKBP12-FK506-calcineurin complex.
Aldape RA; Futer O; DeCenzo MT; Jarrett BP; Murcko MA; Livingston DJ
J Biol Chem; 1992 Aug; 267(23):16029-32. PubMed ID: 1379588
[TBL] [Abstract][Full Text] [Related]
17. Targets of immunophilin-immunosuppressant complexes are distinct highly conserved regions of calcineurin A.
Cardenas ME; Muir RS; Breuder T; Heitman J
EMBO J; 1995 Jun; 14(12):2772-83. PubMed ID: 7540976
[TBL] [Abstract][Full Text] [Related]
18. The immunophilins, FK506 binding protein and cyclophilin, are discretely localized in the brain: relationship to calcineurin.
Dawson TM; Steiner JP; Lyons WE; Fotuhi M; Blue M; Snyder SH
Neuroscience; 1994 Sep; 62(2):569-80. PubMed ID: 7530348
[TBL] [Abstract][Full Text] [Related]
19. Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin.
Tamura K; Fujimura T; Iwasaki K; Sakuma S; Fujitsu T; Nakamura K; Shimomura K; Kuno T; Tanaka C; Kobayashi M
Biochem Biophys Res Commun; 1994 Jul; 202(1):437-43. PubMed ID: 7518678
[TBL] [Abstract][Full Text] [Related]
20. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location.
Bram RJ; Hung DT; Martin PK; Schreiber SL; Crabtree GR
Mol Cell Biol; 1993 Aug; 13(8):4760-9. PubMed ID: 7687744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
